TS
CVS icon

Thomas Steyer’s CVS Health CVS Stock Holding History

Thomas Steyer’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-694,259
Closed -$64.7M – 197
2022
Q4 		$64.7M Sell
694,259
-562,000
-45% -$54.2M 0.38% 58
2022
Q3 		$120M Buy
1,256,259
+10,000
+0.8% +$990K 0.66% 47
2022
Q2 		$115M Buy
1,246,259
+59,976
+5% +$5.85M 0.63% 47
2022
Q1 		$120M Sell
1,186,283
-95,173
-7% -$10M 0.58% 44
2021
Q4 		$132M Buy
1,281,456
+1,047,456
+448% +$96.8M 0.66% 40
2021
Q3 		$19.9M Buy
+234,000
New +$19.6M 0.09% 102
2020
Q1 		– Sell
-750,000
Closed -$55.7M – 106
2019
Q4 		$55.7M Sell
750,000
-150,000
-17% -$10.5M 0.38% 53
2019
Q3 		$56.8M Buy
900,000
+77,500
+9% +$4.59M 0.43% 47
2019
Q2 		$44.8M Buy
822,500
+197,500
+32% +$10.6M 0.29% 58
2019
Q1 		$33.7M Sell
625,000
-305,000
-33% -$18.8M 0.25% 60
2018
Q4 		$60.9M Buy
+930,000
New +$69.4M 0.45% 43

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Thomas Steyer's CVS Position: Q1 2023 in Review

Thomas Steyer sold out of CVS Health (CVS) in Q1 2023, closing a stake of 694,259 shares — an estimated $64.7M sold.

Thomas Steyer first reported a position in CVS in Q4 2018 and held it in 11 quarters. The position peaked at $132M in Q4 2021. 2,270 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Thomas Steyer reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Thomas Steyer sold 694,259 CVS Health shares in Q1 2023, an estimated $64.7M.
  • Thomas Steyer first reported a position in CVS Health in Q4 2018 and held it in 11 quarters.
  • Thomas Steyer's CVS Health position peaked at $132M in Q4 2021.
  • 2,270 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.